Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             139 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adjuvanticity and protective immunity of Plasmodium yoelii nigeriensis blood-stage soluble antigens encapsulated in fusogenic liposome Dwivedi, Varun
 2009
 27 Supplement 4 p. 473-482
10 p.
 artikel
2 A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults ≥65 years of age Langley, Joanne M.
 2009
 27 Supplement 4 p. 5913-5919
7 p.
 artikel
3 A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults Talaat, Kawsar R.
 2009
 27 Supplement 4 p. 3744-3753
10 p.
 artikel
4 Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer Jasani, B.
 2009
 27 Supplement 4 p. 3401-3404
4 p.
 artikel
5 An assessment of the safety of adolescent and adult tetanus–diphtheria–acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink Yih, W. Katherine
 2009
 27 Supplement 4 p. 4257-4262
6 p.
 artikel
6 An inactivated H5N2 vaccine reduces transmission of highly pathogenic H5N1 avian influenza virus among native chickens Poetri, O.N.
 2009
 27 Supplement 4 p. 2864-2869
6 p.
 artikel
7 A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge Gao, Haifeng
 2009
 27 Supplement 4 p. 5313-5319
7 p.
 artikel
8 A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults Jin, Xia
 2009
 27 Supplement 4 p. 7080-7086
7 p.
 artikel
9 Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine Kitchin, Nicholas
 2009
 27 Supplement 4 p. 5096-5102
7 p.
 artikel
10 A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis Carson, Connor
 2009
 27 Supplement 4 p. 1080-1086
7 p.
 artikel
11 A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials Boge, Thierry
 2009
 27 Supplement 4 p. 5677-5684
8 p.
 artikel
12 A relapse of systemic type juvenile idiopathic arthritis after a rubella vaccination in a patient during a long-term remission period Korematsu, Seigo
 2009
 27 Supplement 4 p. 5041-5042
2 p.
 artikel
13 Ascaris suum infection negatively affects the response to a Mycoplasma hyopneumoniae vaccination and subsequent challenge infection in pigs Steenhard, Nina R.
 2009
 27 Supplement 4 p. 5161-5169
9 p.
 artikel
14 A simple method for evaluating dengue vaccine effectiveness in mice based on levels of viremia caused by intraperitoneal injection of infected culture cells Yamanaka, Atsushi
 2009
 27 Supplement 4 p. 3735-3743
9 p.
 artikel
15 Attitudes towards influenza vaccination of multi-nationality health-care workers in Saudi Arabia Al-Tawfiq, Jaffar A.
 2009
 27 Supplement 4 p. 5538-5541
4 p.
 artikel
16 A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics Hu, Shunlin
 2009
 27 Supplement 4 p. 904-910
7 p.
 artikel
17 Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice Zheng, Nuoyan
 2009
 27 Supplement 4 p. 5001-5007
7 p.
 artikel
18 Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice Quintilio, Wagner
 2009
 27 Supplement 4 p. 4219-4224
6 p.
 artikel
19 Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes Arankalle, Vidya A.
 2009
 27 Supplement 4 p. 1032-1039
8 p.
 artikel
20 Changes in the evolution of meningococcal disease, 2001–2008, Catalonia (Spain) Martínez, Ana I.
 2009
 27 Supplement 4 p. 3496-3498
3 p.
 artikel
21 Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis Horwitz, Marcus A.
 2009
 27 Supplement 4 p. 441-445
5 p.
 artikel
22 Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens Jadhao, Samadhan J.
 2009
 27 Supplement 4 p. 6247-6260
14 p.
 artikel
23 Comparison of humoral and cellular immune responses to a pentavalent modified live virus vaccine in three age groups of calves with maternal antibodies, before and after BVDV type 2 challenge Platt, Ratree
 2009
 27 Supplement 4 p. 4508-4519
12 p.
 artikel
24 Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax® in healthy vaccinia-naive adults Frey, Sharon E.
 2009
 27 Supplement 4 p. 1637-1644
8 p.
 artikel
25 Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1) Yang, Shi-gui
 2009
 27 Supplement 4 p. 7451-7458
8 p.
 artikel
26 Cost–benefit comparisons of investments in improved water supply and cholera vaccination programs Jeuland, Marc
 2009
 27 Supplement 4 p. 3109-3120
12 p.
 artikel
27 Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007 Mizuta, K.
 2009
 27 Supplement 4 p. 3153-3158
6 p.
 artikel
28 Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune® in Brazilian endemic areas Palatnik-de-Sousa, Clarisa B.
 2009
 27 Supplement 4 p. 3505-3512
8 p.
 artikel
29 Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination Aline, Fleur
 2009
 27 Supplement 4 p. 5284-5291
8 p.
 artikel
30 De novo T-lymphocyte responses against baculovirus-derived recombinant influenzavirus hemagglutinin generated by a naive umbilical cord blood model of dendritic cell vaccination Safdar, Amar
 2009
 27 Supplement 4 p. 1479-1484
6 p.
 artikel
31 Differences in the immune response to hepatitis B and Haemophilus influenzae type b vaccines in Guatemalan infants by ethnic group and nutritional status Asturias, Edwin J.
 2009
 27 Supplement 4 p. 3650-3654
5 p.
 artikel
32 Differentiation of field isolates and vaccine strains of infectious laryngotracheitis virus by DNA sequencing Chacón, Jorge Luis
 2009
 27 Supplement 4 p. 6731-6738
8 p.
 artikel
33 Diphtheria: A zoonotic disease in France? Bonmarin, Isabelle
 2009
 27 Supplement 4 p. 4196-4200
5 p.
 artikel
34 Does yellow fever 17D vaccine protect against melanoma? Mastrangelo, G.
 2009
 27 Supplement 4 p. 588-591
4 p.
 artikel
35 Dose response effects of avian influenza (H7N7) vaccination of chickens: Serology, clinical protection and reduction of virus excretion Maas, Riks
 2009
 27 Supplement 4 p. 3592-3597
6 p.
 artikel
36 Do they accept compulsory vaccination? Seale, Holly
 2009
 27 Supplement 4 p. 3022-3025
4 p.
 artikel
37 Dual DNA vaccination of rainbow trout (Oncorhynchus mykiss) against two different rhabdoviruses, VHSV and IHNV, induces specific divalent protection Einer-Jensen, Katja
 2009
 27 Supplement 4 p. 1248-1253
6 p.
 artikel
38 Early life DNA vaccination with the H gene of Canine distemper virus induces robust protection against distemper Jensen, Trine Hammer
 2009
 27 Supplement 4 p. 5178-5183
6 p.
 artikel
39 Editorial Board 2009
 27 Supplement 4 p. CO2-
1 p.
 artikel
40 Editorial Board 2009
 27 Supplement 4 p. CO2-
1 p.
 artikel
41 Editorial Board 2009
 27 Supplement 4 p. CO2-
1 p.
 artikel
42 Editorial Board 2009
 27 Supplement 4 p. CO2-
1 p.
 artikel
43 Editorial Board 2009
 27 Supplement 4 p. CO2-
1 p.
 artikel
44 Editorial Board 2009
 27 Supplement 4 p. CO2-
1 p.
 artikel
45 Editorial Board 2009
 27 Supplement 4 p. CO2-
1 p.
 artikel
46 Editorial Board 2009
 27 Supplement 4 p. CO2-
1 p.
 artikel
47 Editorial Board 2009
 27 Supplement 4 p. CO2-
1 p.
 artikel
48 Editorial Board 2009
 27 Supplement 4 p. CO2-
1 p.
 artikel
49 Effective CD8+ T cell priming and tumor protection by enterotoxin B subunit-conjugated peptides targeted to dendritic cells Fu, Nathalie
 2009
 27 Supplement 4 p. 5252-5258
7 p.
 artikel
50 Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines Pathangey, Latha
 2009
 27 Supplement 4 p. 2707-2711
5 p.
 artikel
51 Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity Martelli, Paolo
 2009
 27 Supplement 4 p. 3788-3799
12 p.
 artikel
52 Enhancement of the immune responses to vaccination against foot-and-mouth disease in mice by oral administration of an extract made from Rhizoma Atractylodis Macrocephalae (RAM) Li, Ruili
 2009
 27 Supplement 4 p. 2094-2098
5 p.
 artikel
53 Evaluation of immune responses and protective efficacy in a goat model following immunization with a coctail of recombinant antigens and a polyprotein of Mycobacterium avium subsp. paratuberculosis Kathaperumal, Kumanan
 2009
 27 Supplement 4 p. 123-135
13 p.
 artikel
54 Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE® against aerosolized rabbitpox virus in a rabbit model Garza, Nicole L.
 2009
 27 Supplement 4 p. 5496-5504
9 p.
 artikel
55 Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults Karron, Ruth A.
 2009
 27 Supplement 4 p. 4953-4960
8 p.
 artikel
56 Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals Rupprecht, Charles E.
 2009
 27 Supplement 4 p. 7141-7148
8 p.
 artikel
57 Excess drug prescriptions during influenza and RSV seasons in the Netherlands: Potential implications for extended influenza vaccination Assink, M.D.M.
 2009
 27 Supplement 4 p. 1119-1126
8 p.
 artikel
58 First data on Eurasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain Ballesteros, C.
 2009
 27 Supplement 4 p. 6662-6668
7 p.
 artikel
59 Forecasting demand for Hib-containing vaccine in the world's poorest countries: A 4-year prospective experience Zuber, Patrick L.F.
 2009
 27 Supplement 4 p. 410-415
6 p.
 artikel
60 Genetic immunization with GPI-anchored anthrax protective antigen raises combined CD1d- and MHC II-restricted antibody responses by natural killer T cell-mediated help Midha, Shuchi
 2009
 27 Supplement 4 p. 1700-1709
10 p.
 artikel
61 Global epidemiology of meningococcal disease Harrison, Lee H.
 2009
 27 Supplement 4 p. B51-B63
nvt p.
 artikel
62 Homologous prime-boost strategy in neonate mice using Neisseria lactamica Ito, André Y.
 2009
 27 Supplement 4 p. 3422-3428
7 p.
 artikel
63 How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands Coupé, Veerle M.H.
 2009
 27 Supplement 4 p. 5111-5119
9 p.
 artikel
64 HSP70 fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus enhanced the immune responses and protective efficacy against virulent PRRSV challenge in pigs Li, Junxing
 2009
 27 Supplement 4 p. 825-832
8 p.
 artikel
65 Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5 Zhou, Mingguang
 2009
 27 Supplement 4 p. 5271-5277
7 p.
 artikel
66 IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: Effect of vaccine antigen content Hendrikx, Lotte H.
 2009
 27 Supplement 4 p. 6530-6536
7 p.
 artikel
67 Immune response and prophylactic efficacy of smegmosomes in a hamster model of leptospirosis Faisal, Syed M.
 2009
 27 Supplement 4 p. 6129-6136
8 p.
 artikel
68 Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: A randomized, placebo-controlled trial Kanungo, Suman
 2009
 27 Supplement 4 p. 6887-6893
7 p.
 artikel
69 Immunization of young African green monkeys with OprF epitope 8–OprI–type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa Weimer, Eric T.
 2009
 27 Supplement 4 p. 6762-6769
8 p.
 artikel
70 Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: A potential vaccine candidate Rojas-Caraballo, Jose
 2009
 27 Supplement 4 p. 2870-2876
7 p.
 artikel
71 Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration Künzi, Valérie
 2009
 27 Supplement 4 p. 3561-3567
7 p.
 artikel
72 Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months–2 years or 2–6 years primed with measles-mumps-rubella (MMR) vaccine Gillet, Y.
 2009
 27 Supplement 4 p. 446-453
8 p.
 artikel
73 Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses Shao, Hsiao-Yun
 2009
 27 Supplement 4 p. 5460-5471
12 p.
 artikel
74 Immunological responses to pneumococcal vaccine in frail older people Ridda, I.
 2009
 27 Supplement 4 p. 1628-1636
9 p.
 artikel
75 Immunology of combining CRM197 conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants Lagos, Rosanna
 2009
 27 Supplement 4 p. 2299-2305
7 p.
 artikel
76 Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity de Vries, J.J.C.
 2009
 27 Supplement 4 p. 947-955
9 p.
 artikel
77 Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus Kreijtz, J.H.C.M.
 2009
 27 Supplement 4 p. 4983-4989
7 p.
 artikel
78 Infection with a low virulent Mycoplasma hyopneumoniae isolate does not protect piglets against subsequent infection with a highly virulent M. hyopneumoniae isolate Villarreal, I.
 2009
 27 Supplement 4 p. 1875-1879
5 p.
 artikel
79 Influence of cytokine gene variations on immunization to childhood vaccines Yucesoy, Berran
 2009
 27 Supplement 4 p. 6991-6997
7 p.
 artikel
80 Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination Ovsyannikova, Inna G.
 2009
 27 Supplement 4 p. 3359-3366
8 p.
 artikel
81 Influence of the route of administration on immunomodulatory properties of bovine β-lactoglobulin-producing Lactobacillus casei Hazebrouck, S.
 2009
 27 Supplement 4 p. 5800-5805
6 p.
 artikel
82 In silico prediction and ex vivo evaluation of potential T-cell epitopes in glycoproteins 4 and 5 and nucleocapsid protein of genotype-I (European) of porcine reproductive and respiratory syndrome virus Díaz, Ivan
 2009
 27 Supplement 4 p. 5603-5611
9 p.
 artikel
83 International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19–20 July 2007 Tondella, M.L.
 2009
 27 Supplement 4 p. 803-814
12 p.
 artikel
84 Intragastric administration of attenuated Salmonella typhimurium harbouring transmissible gastroenteritis virus (TGEV) DNA vaccine induced specific antibody production Yang, Heng
 2009
 27 Supplement 4 p. 5035-5040
6 p.
 artikel
85 Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice Oma, Keita
 2009
 27 Supplement 4 p. 3181-3188
8 p.
 artikel
86 Is the vaccination coverage established enough to control pertussis, or it is a re-emerging disease? Cardeñosa, Neus
 2009
 27 Supplement 4 p. 3489-3491
3 p.
 artikel
87 KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major Bhaumik, Suniti
 2009
 27 Supplement 4 p. 1306-1316
11 p.
 artikel
88 Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen Bråve, Andreas
 2009
 27 Supplement 4 p. 3692-3696
5 p.
 artikel
89 Leptosome-entrapped leptospiral antigens conferred significant higher levels of protection than those entrapped with PC-liposomes in a hamster model Faisal, Syed M.
 2009
 27 Supplement 4 p. 6537-6545
9 p.
 artikel
90 Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity Faisal, Syed M.
 2009
 27 Supplement 4 p. 378-387
10 p.
 artikel
91 Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus Sasaki, Takashi
 2009
 27 Supplement 4 p. 5174-5177
4 p.
 artikel
92 Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization Leifer, Immanuel
 2009
 27 Supplement 4 p. 6522-6529
8 p.
 artikel
93 Molecular epidemiology of Japanese encephalitis in East Asia Morita, Kouichi
 2009
 27 Supplement 4 p. 7131-7132
2 p.
 artikel
94 Molecular insight into the immune up-regulatory properties of the leaf extract of Ashwagandha and identification of Th1 immunostimulatory chemical entity Khan, Sheema
 2009
 27 Supplement 4 p. 6080-6087
8 p.
 artikel
95 Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens Gómez, Carmen E.
 2009
 27 Supplement 4 p. 3165-3174
10 p.
 artikel
96 National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: Emergence of serotype 19A with high invasive potential Hsieh, Yu-Chia
 2009
 27 Supplement 4 p. 5513-5518
6 p.
 artikel
97 N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infection Hill, Jim
 2009
 27 Supplement 4 p. 7073-7079
7 p.
 artikel
98 Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity Sun, Hong-Xiang
 2009
 27 Supplement 4 p. 3984-3991
8 p.
 artikel
99 Optimized subunit vaccine protects against experimental leishmaniasis Bertholet, Sylvie
 2009
 27 Supplement 4 p. 7036-7045
10 p.
 artikel
100 Pertussis before and after the introduction of acellular pertussis vaccines in Finland Elomaa, Annika
 2009
 27 Supplement 4 p. 5443-5449
7 p.
 artikel
101 Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa Freeman, Esther E.
 2009
 27 Supplement 4 p. 940-946
7 p.
 artikel
102 Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia Wood, James G.
 2009
 27 Supplement 4 p. 313-318
6 p.
 artikel
103 Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa Lee, Che-Hung
 2009
 27 Supplement 4 p. 726-732
7 p.
 artikel
104 Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus Biesova, Zuzana
 2009
 27 Supplement 4 p. 6234-6238
5 p.
 artikel
105 Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy Dudareva, M.
 2009
 27 Supplement 4 p. 3501-3504
4 p.
 artikel
106 Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus Van Reeth, Kristien
 2009
 27 Supplement 4 p. 6330-6339
10 p.
 artikel
107 Protection of Japanese flounder (Paralichthys olivaceus) against Vibrio anguillarum with a DNA vaccine containing the mutated zinc-metalloprotease gene Yang, Hui
 2009
 27 Supplement 4 p. 2150-2155
6 p.
 artikel
108 Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model Ahmad, Gul
 2009
 27 Supplement 4 p. 2830-2837
8 p.
 artikel
109 Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus Guthrie, Alan J.
 2009
 27 Supplement 4 p. 4434-4438
5 p.
 artikel
110 Quadrivalent meningococcal conjugate vaccines Pace, David
 2009
 27 Supplement 4 p. B30-B41
nvt p.
 artikel
111 Qualitative differences in the early immune response to live and killed Leishmania major: Implications for vaccination strategies against Leishmaniasis Okwor, Ifeoma
 2009
 27 Supplement 4 p. 2554-2562
9 p.
 artikel
112 Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines Franka, Richard
 2009
 27 Supplement 4 p. 7149-7155
7 p.
 artikel
113 Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response Mahalanabis, D.
 2009
 27 Supplement 4 p. 4850-4856
7 p.
 artikel
114 Recombinant attenuated Salmonella harboring 4-1BB ligand gene enhances cellular immunity Ye, Jian-xin
 2009
 27 Supplement 4 p. 1717-1723
7 p.
 artikel
115 Recombinant glycoprotein based vaccine for Chandipura virus infection Venkateswarlu, C.H.
 2009
 27 Supplement 4 p. 2845-2850
6 p.
 artikel
116 Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease Granoff, Dan M.
 2009
 27 Supplement 4 p. B117-B125
nvt p.
 artikel
117 Role of lipopolysaccharide in the induction of type I interferon-dependent cross-priming and IL-10 production in mice by meningococcal outer membrane vesicles Durand, Vanessa
 2009
 27 Supplement 4 p. 1912-1922
11 p.
 artikel
118 Saccharomyces cerevisiae as a vaccine against coccidioidomycosis Capilla, Javier
 2009
 27 Supplement 4 p. 3662-3668
7 p.
 artikel
119 Safety and immunogenicity of a hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 3, 4, and 12–14 months of age Halperin, Scott A.
 2009
 27 Supplement 4 p. 2540-2547
8 p.
 artikel
120 Safety and immunogenicity of sequential pneumococcal immunization in preschool asthmatics Rose, Markus A.
 2009
 27 Supplement 4 p. 5259-5264
6 p.
 artikel
121 Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs Kyriakis, Constantinos S.
 2009
 27 Supplement 4 p. 2258-2264
7 p.
 artikel
122 Scheduling of measles vaccination in low-income countries: Projections of a dynamic model Bauch, C.T.
 2009
 27 Supplement 4 p. 4090-4098
9 p.
 artikel
123 Seroprevalence of bactericidal antibody against Neisseria meningitidis serogroup C in pre-vaccinal era: The Italian epidemiological scenario Gasparini, R.
 2009
 27 Supplement 4 p. 3435-3438
4 p.
 artikel
124 Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000–2006 Tyrrell, Gregory J.
 2009
 27 Supplement 4 p. 3553-3560
8 p.
 artikel
125 sopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria Nagarajan, Arvindhan G.
 2009
 27 Supplement 4 p. 2804-2811
8 p.
 artikel
126 Synthetic peptides from conserved regions of the Plasmodium falciparum early transcribed membrane and ring exported proteins bind specifically to red blood cell proteins Garcia, Jeison
 2009
 27 Supplement 4 p. 6877-6886
10 p.
 artikel
127 T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune® Araújo, Márcio Sobreira Silva
 2009
 27 Supplement 4 p. 1008-1017
10 p.
 artikel
128 The contribution of naturally occurring IgM antibodies, IgM cross-reactivity and complement dependency in murine humoral responses to pneumococcal capsular polysaccharides Jones, Hannah E.
 2009
 27 Supplement 4 p. 5806-5815
10 p.
 artikel
129 The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine Silfverdal, Sven Arne
 2009
 27 Supplement 4 p. 1601-1608
8 p.
 artikel
130 The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix Maciag, Paulo Cesar
 2009
 27 Supplement 4 p. 3975-3983
9 p.
 artikel
131 The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap Heldens, J.G.M.
 2009
 27 Supplement 4 p. 5530-5537
8 p.
 artikel
132 The temperature-sensitive mutants of Toxoplasma gondii and ocular toxoplasmosis Lu, Fangli
 2009
 27 Supplement 4 p. 573-580
8 p.
 artikel
133 Th1-type epitopes-based cocktail PDDV attenuates hepatic fibrosis in C57BL/6 mice with chronic Schistosoma japonicum infection Tao, Fang-Fang
 2009
 27 Supplement 4 p. 4110-4117
8 p.
 artikel
134 TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model Cyr, Sonya L.
 2009
 27 Supplement 4 p. 421-430
10 p.
 artikel
135 Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice Peng, Gao-Hui
 2009
 27 Supplement 4 p. 6570-6574
5 p.
 artikel
136 Transmission-dynamic model to capture the indirect effects of infant vaccination with Prevnar (7-valent pneumococcal conjugate vaccine (PCV7)) in older populations Snedecor, Sonya J.
 2009
 27 Supplement 4 p. 4694-4703
10 p.
 artikel
137 Universal childhood immunisation against Streptococcus pneumoniae: The five-year experience of Liguria Region, Italy Durando, Paolo
 2009
 27 Supplement 4 p. 3459-3462
4 p.
 artikel
138 Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen Mealey, Robert H.
 2009
 27 Supplement 4 p. 2453-2468
16 p.
 artikel
139 Virulence and antigenicity of the szp-gene deleted Streptococcus equi ssp. zooepidemicus mutant in mice Hong-jie, Fan
 2009
 27 Supplement 4 p. 56-61
6 p.
 artikel
                             139 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland